Popping a daily antihistamine has been the default allergy strategy for decades manage the symptoms, repeat tomorrow. But future allergy treatment is shifting toward something more ambitious: addressing the underlying immune response itself, rather than just blocking its symptoms.

At the New York Institute of Otolaryngology, Dr. Raj and the ENT team work with allergy patients throughout Brooklyn and Rego Park who are increasingly asking about options beyond the pharmacy aisle treatments that offer lasting change rather than daily maintenance.

This piece covers where allergy care stands today, how immunotherapy actually works, the growing role of biologics, what's on the horizon, and what all of this means for someone deciding on their own treatment path.

Where Allergy Care Stands

Most allergy treatment today falls into two broad categories:

Symptom management antihistamines, decongestants, and nasal steroids, which reduce symptoms but don't change the underlying allergic response and require ongoing use

Immune-modifying treatment approaches like immunotherapy and biologics, which aim to actually change how the immune system responds to allergens, sometimes with long-term or even lasting effect after treatment ends

The vast majority of allergy sufferers still rely primarily on symptom management, largely because it's accessible, familiar, and effective enough for milder cases. But for people with significant, persistent, or treatment-resistant allergies, the immune-modifying category has expanded considerably and is where most of the meaningful innovation is happening.

Immunotherapy Explained

Allergy immunotherapy isn't new allergy shots have existed for over a century but the delivery methods and precision of modern immunotherapy have improved significantly.

Subcutaneous immunotherapy (SCIT) traditional allergy shots, given regularly over several years, gradually desensitizing the immune system to specific allergens

Sublingual immunotherapy (SLIT) allergen extracts placed under the tongue rather than injected, offering a needle-free option that can often be done at home after an initial supervised dose

More precise allergen selection, using better testing to target the specific proteins driving a person's allergic response, rather than broader, less targeted extracts

Shorter treatment protocols in development, aiming to achieve meaningful desensitization in less time than the traditional 3–5 year course

The core idea behind immunotherapy hasn't changed expose the immune system to gradually increasing amounts of an allergen to build tolerance but the delivery, precision, and patient experience have all improved meaningfully.

The Rise of Biologics

Biologics allergy treatments represent one of the more significant shifts in recent allergy care. These are injectable medications that target specific molecules involved in the allergic immune response, rather than broadly suppressing symptoms.

Targeted mechanism biologics block specific antibodies or immune signaling molecules (like IgE or certain interleukins) that drive allergic inflammation, rather than acting broadly like antihistamines

Originally developed for severe asthma and chronic hives, biologics have expanded into treatment for chronic sinusitis with nasal polyps and severe allergic conditions that don't respond well to standard treatment

Meaningful symptom reduction in patients with treatment-resistant chronic conditions, sometimes allowing reduction or elimination of other medications

Higher cost and more involved administration compared to antihistamines, typically requiring injections on a regular schedule and closer medical supervision

Biologics aren't a replacement for standard allergy treatment for most people they're generally reserved for more severe, treatment-resistant cases where standard approaches haven't provided adequate relief.

What's on the Horizon

Several developing areas suggest where allergy treatment may head next:

More precise, personalized allergen immunotherapy, potentially guided by more detailed molecular allergy testing to build highly individualized treatment plans

Oral immunotherapy expansion, particularly for food allergies, building on approaches already approved for certain allergens

New biologic targets, as research identifies additional immune pathways involved in allergic disease beyond those currently targeted

Combination approaches, pairing immunotherapy with biologics or other treatments to accelerate or enhance desensitization

Improved delivery methods, including patches or other non-injection routes for treatments that currently require needles

Much of this research is still in earlier stages, and the timeline for widespread availability varies significantly by specific treatment and condition.

What It Means for You

For most people with mild to moderate seasonal allergies, standard treatment antihistamines, nasal steroids, and basic avoidance strategies remains a reasonable and effective first-line approach. The expanding treatment landscape matters most for:

People with allergies significant enough to affect quality of life despite consistent use of standard treatments

Those interested in a potentially lasting solution rather than ongoing daily symptom management, for whom immunotherapy may be worth discussing

Patients with chronic sinusitis, nasal polyps, or severe allergic asthma who haven't responded adequately to standard treatment, for whom biologics may be a relevant option

Anyone curious about more targeted testing to better understand their specific allergen triggers, which increasingly informs more personalized treatment planning

An allergist or ENT can help determine whether your specific situation warrants moving beyond symptom management, and which of these approaches if any fits your particular case.

FAQs

1. Are allergy shots still relevant given newer treatments? Yes. Immunotherapy, including traditional allergy shots, remains one of the few treatments that can produce lasting change in the immune response, and it continues to be refined with better precision and delivery methods.

2. What's the difference between immunotherapy and biologics? Immunotherapy gradually builds tolerance to specific allergens through repeated exposure. Biologics block specific immune molecules involved in the allergic response, generally used for more severe or treatment-resistant conditions.

3. Are biologics a cure for allergies? No. Biologics manage and often significantly reduce symptoms in treatment-resistant cases, but they aren't currently considered a cure and typically require ongoing use.

4. How long does immunotherapy take to work? Traditional courses typically run 3–5 years for full effect, though sublingual options and other approaches may offer somewhat different timelines depending on the specific treatment plan.

5. Are sublingual allergy drops as effective as allergy shots? Sublingual immunotherapy can be effective for certain allergens, though effectiveness varies by allergen type and individual response. Your allergist can help determine which option suits your specific allergies.

6. Who is a candidate for biologic allergy treatment? Biologics are generally considered for patients with severe, treatment-resistant conditions like significant nasal polyps, severe allergic asthma, or chronic hives that haven't responded to standard treatment.

7. Is oral immunotherapy for food allergies widely available? Availability varies by specific food allergen and treatment, with some options already approved and others still in development or limited availability.

8. Do newer allergy treatments eliminate the need for antihistamines? Not necessarily. Many patients on immunotherapy or biologics still use antihistamines for breakthrough symptoms, particularly during high-exposure periods.

9. How much do biologics for allergies typically cost? Biologics are generally more expensive than standard allergy medications and require ongoing administration, though cost varies by specific medication and insurance coverage.